DEVICE CATEGORY · NIQ
Coronary Drug-Eluting Stent
Stent, coronary, drug-eluting -- a metal scaffold with a drug coating placed via a delivery catheter into the coronary artery or saphenous vein graft to maintain the lumen. The drug coating is intended to inhibit restenosis.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Vascular | PMA supplement | Oct 16, 2026 | FDA | |
| Abbott Vascular | PMA supplement | Oct 1, 2026 | FDA | |
ORSIRO Sirolimus Eluting Coronary Stent SystemP170030/S066 | Biotronik AG | PMA supplement | Sep 24, 2026 | FDA |
| Abbott Vascular | PMA supplement | Aug 28, 2026 | FDA | |
| BOSTON SCIENTIFIC CORPORATION | PMA supplement | Aug 21, 2026 | FDA | |
| Medtronic Vascular | PMA supplement | Aug 14, 2026 | FDA | |
ORSIRO Sirolimus Eluting Coronary Stent SystemP170030/S065 | Biotronik AG | PMA supplement | Aug 7, 2026 | FDA |
| Medinol, Ltd. | PMA supplement | Aug 6, 2026 | FDA | |
| Abbott Vascular | PMA supplement | Jul 31, 2026 | FDA | |
| Biotronik AG | PMA supplement | Jul 23, 2026 | FDA | |
| Biotronik AG | PMA supplement | Jun 11, 2026 | FDA | |
| Medtronic Vascular | PMA supplement | Jun 5, 2026 | FDA | |
| Biotronik AG | PMA supplement | Jun 5, 2026 | FDA | |
| Medtronic Vascular | PMA supplement | May 29, 2026 | FDA | |
| Abbott Vascular | PMA supplement | May 22, 2026 | FDA | |
| Medtronic Vascular | PMA supplement | May 13, 2026 | FDA | |
| Biotronik AG | PMA supplement | Apr 15, 2026 | FDA | |
ORSIRO Sirolimus Eluting Coronary Stent SystemP170030/S062 | Biotronik AG | PMA supplement | Apr 15, 2026 | FDA |
| Biotronik AG | PMA supplement | Apr 1, 2026 | FDA | |
| Medinol, Ltd. | PMA supplement | Mar 26, 2026 | FDA | |
| Medtronic Vascular | PMA supplement | Mar 25, 2026 | FDA | |
| Biotronik AG | PMA supplement | Feb 22, 2026 | FDA | |
| Biotronik AG | PMA supplement | Feb 20, 2026 | FDA | |
| Abbott Vascular | PMA supplement | Feb 13, 2026 | FDA | |
| Abbott Vascular | PMA supplement | Feb 5, 2026 | FDA | |
| Medinol, Ltd. | PMA supplement | Feb 4, 2026 | FDA | |
| Abbott Vascular | PMA supplement | Feb 3, 2026 | FDA | |
| Medtronic Vascular | PMA supplement | Dec 19, 2025 | FDA | |
| BOSTON SCIENTIFIC CORPORATION | PMA supplement | Oct 29, 2025 | FDA | |
| Abbott Vascular | PMA supplement | Oct 22, 2025 | FDA | |
| Biotronik AG | PMA supplement | Oct 10, 2025 | FDA | |
| Medinol, Ltd. | PMA supplement | Oct 2, 2025 | FDA | |
| Biotronik AG | PMA supplement | Aug 19, 2025 | FDA | |
| Abbott Vascular | PMA supplement | Aug 16, 2025 | FDA | |
| Medinol, Ltd. | PMA supplement | Aug 15, 2025 | FDA | |
| Medinol, Ltd. | PMA supplement | Aug 7, 2025 | FDA | |
| Biotronik AG | PMA approval | Feb 22, 2019 | FDA | |
| Medtronic Vascular | PMA approval | Apr 28, 2017 | FDA | |
| Abbott Vascular | PMA approval | Nov 1, 2011 | FDA |
Source information
Follow the FDA links to view the original records.







